Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

Recent & Breaking News (TSXV:TLT)

Theralase Demonstrates Increased Efficacy for Latest Anti-Cancer Drug

Filing Services Canada September 12, 2017

Theralase Anti-Cancer Drugs Effective in the Destruction of Cervical Cancer

Filing Services Canada September 5, 2017

Theralase Increases Revenue 14% for 2Q2017 Financial Statements

Filing Services Canada August 29, 2017

Theralase Anti-Cancer Drugs Independently Verified and Validated

Filing Services Canada August 22, 2017

Theralase Anti-Cancer Technology Effective for the Destruction of Lung Cancer

Filing Services Canada August 8, 2017

Theralase PDT Technology Used to Treat Fourth Patient for Bladder Cancer

Filing Services Canada August 1, 2017

Theralase Tech reaches efficiency milestone for anti-cancer treatment

Stockhouse Editorial July 25, 2017

Theralase Achieves Exploratory Endpoint of Efficacy for Anti-Cancer Technology

Filing Services Canada July 25, 2017

Theralase Releases Annual and Special Meeting Videos

Filing Services Canada July 5, 2017

Theralase Provides Clarification Regarding Certain Forward-Looking Statements

Filing Services Canada June 30, 2017

Theralase Technology Proven Effective for the Treatment of Arthritis

Filing Services Canada June 29, 2017

Theralase Researcher Granted Second US Patent for Novel Anti-Cancer Drugs

Filing Services Canada June 26, 2017

Theralase Presents Phosphorescent Photosensitizers at International World Congress

Filing Services Canada June 15, 2017

Theralase Presents X-Ray Activation at International World Congress

Filing Services Canada June 14, 2017

Theralase Presents Dosimetry Planning at International World Congress

Filing Services Canada June 13, 2017

OTC Markets Group Welcomes Theralase Technologies Inc. to OTCQX

PR Newswire June 2, 2017

Theralase Commences Trading on OTCQX

Filing Services Canada June 2, 2017

Theralase Increases Revenue 23% for 1Q2017 Financial Statements

Filing Services Canada May 30, 2017

Theralase says objectives for anti-cancer treatment have been met

Stockhouse Editorial May 26, 2017

Theralase Successfully Achieves Primary and Secondary Objectives for First Three Patients Treated Using Anti-Cancer Technology for Bladder Cancer

Filing Services Canada May 26, 2017